Lamisil At
Pricing Report NDC 0067-8100-30

Latest NADAC: $0.37352 per GM · Effective Dec 18, 2019 · Est. package price $11.21 (30 GM)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Lamisil At (NDC 0067-8100-30) is $0.37352 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 18, 2019.

As a provided by Haleon Us Holdings Llc, this medication is distributed in a 1 TUBE in 1 CARTON / 30 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.37352
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Dec 18, 2019
Billable Units
30 GM
Estimated Package Price
$11.21
Data Status
As of Jul 01, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
0067-8100-30
Description
1 TUBE in 1 CARTON / 30 g in 1 TUBE
Generic Benchmark
The generic equivalent rate is $0.28903 (Effective: Jun 17, 2020)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.35398 to $0.64778 per GM. Over this 6 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3545 - $0.6478
Market Volatility
82.74% Variance
Latest Trend
65.54%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 18, 2020 $0.61833 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 18, 2020 $0.61833 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 18, 2020 $0.61833 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 18, 2019 $0.37352 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Nov 20, 2019 $0.38811 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 21, 2019 $0.63292 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026